Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Thompson

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Annals of Clinical and Translational Neurology|September 12, 2025
Assessing a Mitochondrial Disease Treatment via a Novel Statistical Technique for Accelerometer DataIan W McKeague, Kristin Engelstad, Yue Ge, et al.
American Journal of Medical Genetics|February 15, 1992
Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased riskM Huggins, M Bloch, S Wiggins, et al.
Journal of Inherited Metabolic Disease|December 28, 2020
Regulatory environment for novel therapeutic development in mitochondrial diseasesMichio Hirano, Andres Berardo, Emanuele Barca, et al.
ESC Heart Failure|December 30, 2020
Prognostic impact of 6 min walk test distance in patients with systolic heart failure: insights from the WARCEF trialKenji Matsumoto, Yi Xiao, Shunichi Homma, et al.
Neurology|January 12, 2005
The ALSFRSr predicts survival time in an ALS clinic populationP Kaufmann, G Levy, J L P Thompson, et al.
ESC Heart Failure|September 21, 2021
Left ventricular dimensions and cardiovascular outcomes in systolic heart failure: the WARCEF trialKazato Ito, Siyuan Li, Shunichi Homma, et al.
Therapeutic Advances in Rare Disease|March 6, 2024
A United States-based patient-reported adult polyglucosan body disease registry: initial resultsJacy Sparks, Francesco Michelassi, John L P Thompson, et al.
Neurology|March 15, 2006
A two-stage design for a phase II clinical trial of coenzyme Q10 in ALSG Levy, P Kaufmann, R Buchsbaum, et al.
Human Reproduction (Oxford, England)|March 4, 2016
Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapyKristin Engelstad, Miriam Sklerov, Joshua Kriger, et al.
Internal and Emergency Medicine|February 23, 2024
Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trialGiulio Francesco Romiti, Katarzyna Nabrdalik, Bernadette Corica, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Annals of Clinical and Translational Neurology|September 12, 2025
Assessing a Mitochondrial Disease Treatment via a Novel Statistical Technique for Accelerometer DataIan W McKeague, Kristin Engelstad, Yue Ge, et al.
American Journal of Medical Genetics|February 15, 1992
Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased riskM Huggins, M Bloch, S Wiggins, et al.
Journal of Inherited Metabolic Disease|December 28, 2020
Regulatory environment for novel therapeutic development in mitochondrial diseasesMichio Hirano, Andres Berardo, Emanuele Barca, et al.
ESC Heart Failure|December 30, 2020
Prognostic impact of 6 min walk test distance in patients with systolic heart failure: insights from the WARCEF trialKenji Matsumoto, Yi Xiao, Shunichi Homma, et al.
Neurology|January 12, 2005
The ALSFRSr predicts survival time in an ALS clinic populationP Kaufmann, G Levy, J L P Thompson, et al.
ESC Heart Failure|September 21, 2021
Left ventricular dimensions and cardiovascular outcomes in systolic heart failure: the WARCEF trialKazato Ito, Siyuan Li, Shunichi Homma, et al.
Therapeutic Advances in Rare Disease|March 6, 2024
A United States-based patient-reported adult polyglucosan body disease registry: initial resultsJacy Sparks, Francesco Michelassi, John L P Thompson, et al.
Neurology|March 15, 2006
A two-stage design for a phase II clinical trial of coenzyme Q10 in ALSG Levy, P Kaufmann, R Buchsbaum, et al.
Human Reproduction (Oxford, England)|March 4, 2016
Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapyKristin Engelstad, Miriam Sklerov, Joshua Kriger, et al.
Internal and Emergency Medicine|February 23, 2024
Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trialGiulio Francesco Romiti, Katarzyna Nabrdalik, Bernadette Corica, et al.
Pageof 9